{"pmid":32281667,"title":"Coronavirus disease 2019: new things to know!","text":["Coronavirus disease 2019: new things to know!","We have read with interest the review of Feng et al. \"Coronavirus Disease 2019 (COVID-19): What we know?\" 1 which report the clinical features, diagnosis and treatment of the novel Coronavirus Disease 2019 (COVID-19). This article is protected by copyright. All rights reserved.","J Med Virol","Zayet, Souheil","N'dri Juliette, Kadiane-Oussou","Royer, Pierre-Yves","Toko, Lynda","Gendrin, Vincent","Klopfenstein, Timothee","32281667"],"abstract":["We have read with interest the review of Feng et al. \"Coronavirus Disease 2019 (COVID-19): What we know?\" 1 which report the clinical features, diagnosis and treatment of the novel Coronavirus Disease 2019 (COVID-19). This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Zayet, Souheil","N'dri Juliette, Kadiane-Oussou","Royer, Pierre-Yves","Toko, Lynda","Gendrin, Vincent","Klopfenstein, Timothee"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32281667","week":"202016|Apr 13 - Apr 19","doi":"10.1002/jmv.25874","source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1663989232500211712,"score":7.979339,"similar":[{"pmid":32266994,"title":"Comment on \"Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19\".","text":["Comment on \"Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19\".","We read with great interest the article by Cheng H et al. The authors mentioned that angiotensin-converting enzyme 2 (ACE2) is protective against novel coronavirus disease 2019 (COVID-19). We would like to explain how cytosolic pH increases the COVID-19 infection by affecting the ACE2. In addition, we would like to mention that amiloride, which increases the cytosolic pH, can be used in the COVID-19 treatment. This article is protected by copyright. All rights reserved.","J Med Virol","Cure, Erkan","Cumhur Cure, Medine","32266994"],"abstract":["We read with great interest the article by Cheng H et al. The authors mentioned that angiotensin-converting enzyme 2 (ACE2) is protective against novel coronavirus disease 2019 (COVID-19). We would like to explain how cytosolic pH increases the COVID-19 infection by affecting the ACE2. In addition, we would like to mention that amiloride, which increases the cytosolic pH, can be used in the COVID-19 treatment. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Cure, Erkan","Cumhur Cure, Medine"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32266994","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25848","keywords":["ACE2","ACEI","ARBs","ARDS","Amiloride","COVID-19","SARS-CoV-2","acute respiratory distress syndrome","angiotensin II receptor blockers","angiotensin-converting enzyme 2","angiotensin-converting enzyme inhibitors","coronavirus disease 2019","cytosolic pH"],"source":"PubMed","weight":0,"e_drugs":["Amiloride"],"_version_":1663609715724124161,"score":75.44906},{"pmid":32239511,"title":"Sore throat in COVID-19: comment on \"Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis\".","text":["Sore throat in COVID-19: comment on \"Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis\".","We read with interest the recent meta-analysis by Sun et al.(1) that included 50466 patients with Coronavirus Disease 2019 (COVID-19). The author found that fever and cough were the most common symptoms, and several subjects had muscle soreness or fatigue. In addition, they reported that \"by reading the included literature, we found that diarrhea, hemoptysis, headache, sore throat, shock, and other symptoms are rare\".(1) This article is protected by copyright. All rights reserved.","J Med Virol","Lovato, Andrea","Rossettini, Giacomo","de Filippis, Cosimo","32239511"],"abstract":["We read with interest the recent meta-analysis by Sun et al.(1) that included 50466 patients with Coronavirus Disease 2019 (COVID-19). The author found that fever and cough were the most common symptoms, and several subjects had muscle soreness or fatigue. In addition, they reported that \"by reading the included literature, we found that diarrhea, hemoptysis, headache, sore throat, shock, and other symptoms are rare\".(1) This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Lovato, Andrea","Rossettini, Giacomo","de Filippis, Cosimo"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32239511","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25815","source":"PubMed","weight":0,"_version_":1663352135513800705,"score":74.8164},{"pmid":32267000,"title":"Patterns of heart Injury in COVID - 19 and relation to outcome.","text":["Patterns of heart Injury in COVID - 19 and relation to outcome.","We read with much interest the article \"Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China\" by Han et al as published in March 2020. In this retrospective, single center study authors have discussed the role of acute cardiovascular injury marker including CK-MB, Myoglobulin, cardiac troponin I (cTnI) and NT- proBNP on the outcome of 273 patients with COVID-19 disease. This article is protected by copyright. All rights reserved.","J Med Virol","Mishra, Ajay Kumar","Sahu, Kamal Kant","Lal, Amos","Sargent, Jennifer","32267000"],"abstract":["We read with much interest the article \"Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China\" by Han et al as published in March 2020. In this retrospective, single center study authors have discussed the role of acute cardiovascular injury marker including CK-MB, Myoglobulin, cardiac troponin I (cTnI) and NT- proBNP on the outcome of 273 patients with COVID-19 disease. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Mishra, Ajay Kumar","Sahu, Kamal Kant","Lal, Amos","Sargent, Jennifer"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267000","week":"202015|Apr 06 - Apr 12","doi":"10.1002/jmv.25847","source":"PubMed","topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1663609715800670208,"score":71.404434},{"pmid":32239515,"title":"Fecal Transmission in COVID-19: A Potential Shedding Rout.","text":["Fecal Transmission in COVID-19: A Potential Shedding Rout.","We read with interest recent article by Zhang et al (1) on the diagnosis of Coronavirus disease 2019 (COVID-19) by fecal specimen test. Following the recent outbreak of pneumonia with unknown pathogen in Hubei province in China, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolated from human airway epithelial cells and the disease was named COVID-19.(2) It is a public health emergency of international concern and rapidly spearing all over the world.(3) This article is protected by copyright. All rights reserved.","J Med Virol","Nouri-Vaskeh, Masoud","Alizadeh, Leila","32239515"],"abstract":["We read with interest recent article by Zhang et al (1) on the diagnosis of Coronavirus disease 2019 (COVID-19) by fecal specimen test. Following the recent outbreak of pneumonia with unknown pathogen in Hubei province in China, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) isolated from human airway epithelial cells and the disease was named COVID-19.(2) It is a public health emergency of international concern and rapidly spearing all over the world.(3) This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Nouri-Vaskeh, Masoud","Alizadeh, Leila"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32239515","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25816","source":"PubMed","locations":["China","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission"],"weight":1,"_version_":1663352135445643264,"score":71.34983},{"pmid":32227489,"title":"Concerns regarding calculation of fatality rate of Chinese samples in COVID-19 meta-analysis.","text":["Concerns regarding calculation of fatality rate of Chinese samples in COVID-19 meta-analysis.","I read with interest the meta-analysis of patient clinical characteristics and fatality rates in COVID-19 from Chinese samples by Li and colleagues(1) . I was surprised by the fatality rate of 7% which is much than higher than the value of 1.4% reported in a large study of Chinese patients by Guan et al (2020)(2) . This article is protected by copyright. All rights reserved.","J Med Virol","Kempton, Matthew","32227489"],"abstract":["I read with interest the meta-analysis of patient clinical characteristics and fatality rates in COVID-19 from Chinese samples by Li and colleagues(1) . I was surprised by the fatality rate of 7% which is much than higher than the value of 1.4% reported in a large study of Chinese patients by Guan et al (2020)(2) . This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Kempton, Matthew"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32227489","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25799","source":"PubMed","locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1663352135309328384,"score":70.48885}]}